About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3623578
Allelic
Composition
Casp3tm1Mak/Casp3tm1Mak
Tg(TcrLCMV)327Sdz/0
Genetic
Background
B6.Cg-Casp3tm1Mak Tg(TcrLCMV)327Sdz
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Casp3tm1Mak mutation (1 available); any Casp3 mutation (32 available)
Tg(TcrLCMV)327Sdz mutation (11 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• after injection with streptozocin for 5 consecutive days, blood glucose in caspase-3-homozygous transgenic mice remains normoglycemic for the duration of the study

cellular
• adoptive transfer of labeled Tg(TcrLCMV)327Sdz-transgene positive T cells, examination of pancreatic draining lymph nodes showed that only 45% of the transferred T cells had undergone proliferation compared to 62% in caspase-3-heterozygous transgenic recipients

immune system
• in CD8+ T cells isolated from pancreatic draining or non-draining lymph nodes of streptozocin-treated mice, 32% of the CD8+ cells are CD69hi positive and 9% respectively, compared to corresponding values of 3% and 5% respectively in caspase-3-heterozygous transgenic mice

hematopoietic system
• in CD8+ T cells isolated from pancreatic draining or non-draining lymph nodes of streptozocin-treated mice, 32% of the CD8+ cells are CD69hi positive and 9% respectively, compared to corresponding values of 3% and 5% respectively in caspase-3-heterozygous transgenic mice


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/06/2026
MGI 6.24
The Jackson Laboratory